Mitochondrially-targeted treatment strategies
- 19 December 2019
- journal article
- review article
- Published by Elsevier BV in Molecular Aspects of Medicine
- Vol. 71, 100836
- https://doi.org/10.1016/j.mam.2019.100836
Abstract
No abstract availableFunding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2017/16694-2, 2017/16071-5, 2017/16540-5, 2017/24836-1, 2018/19332-7, 2018/18627-3 and)
- FAPESP (2013/07937-8)
- Conselho Nacional de Pesquisa e Desenvolvimento – Brasil (407743/2018-9, 307934/2018-7, 303281/2015-4, 407306/2013-7)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior – Brasil (001.)
This publication has 330 references indexed in Scilit:
- Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- and Age-Induced Diabetes in MiceCell Metabolism, 2011
- In Vivo Correction of COX Deficiency by Activation of the AMPK/PGC-1α AxisCell Metabolism, 2011
- The Cell-Non-Autonomous Nature of Electron Transport Chain-Mediated LongevityCell, 2011
- Regulation of mitochondrial processes: A target for heart failureDrug Discovery Today: Disease Mechanisms, 2010
- Interdependence of AMPK and SIRT1 for Metabolic Adaptation to Fasting and Exercise in Skeletal MuscleCell Metabolism, 2010
- Is multiple sclerosis a mitochondrial disease?Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010
- Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase IIIAnnals of Neurology, 2009
- Doxorubicin Inactivates Myocardial Cytochrome c Oxidase in Rats: Cardioprotection by Mito-QBiophysical Journal, 2009
- Superoxide Flashes in Single MitochondriaCell, 2008
- A Mitochondrial Protein Compendium Elucidates Complex I Disease BiologyCell, 2008